Lloyds, GlaxoSmithKline, and two IPOs with Alan Green

The UK Investor Magazine Podcast is joined by Alan Green to focus on Lloyds shares, GSK and two London IPOs.

Lloyds released its quarterly trading update which alluded to a slowdown in profit from Q4 2021. We discuss their dividend and what it will take for the Lloyds share price to break through 50p and back up towards 70p. With Net Income dipping from Q4 2021, there is also consideration paid to the impact of actions at the Bank of England to Lloyds shares in 2022.

Despite cutting their full year dividend by 35%, GlaxoSmithKline produced a bumper 32% increase in sales in Q1 2021. Given the strong revenue growth, high valuation and reduced dividend, we question whether GSK is now a value, growth or income stock.

We also look at two upcoming London IPOs in Lift Global Ventures and SpectrumX.

Lloyds (LON:LLOY), GlaxoSmithKline (LON:GSK) and Lift Global Ventures (LON:LFT).

Hosted on Acast. See acast.com/privacy for more information.